Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
Proc Natl Acad Sci U S A ; 118(11)2021 03 16.
Artigo em Inglês | MEDLINE | ID: mdl-33692125

RESUMO

Rare genetic mutations result in aggregation and spreading of cognate proteins in neurodegenerative disorders; however, in the absence of mutation (i.e., in the vast majority of "sporadic" cases), mechanisms for protein misfolding/aggregation remain largely unknown. Here, we show environmentally induced nitrosative stress triggers protein aggregation and cell-to-cell spread. In patient brains with amyotrophic lateral sclerosis (ALS)/frontotemporal dementia (FTD), aggregation of the RNA-binding protein TDP-43 constitutes a major component of aberrant cytoplasmic inclusions. We identify a pathological signaling cascade whereby reactive nitrogen species cause S-nitrosylation of TDP-43 (forming SNO-TDP-43) to facilitate disulfide linkage and consequent TDP-43 aggregation. Similar pathological SNO-TDP-43 levels occur in postmortem human FTD/ALS brains and in cell-based models, including human-induced pluripotent stem cell (hiPSC)-derived neurons. Aggregated TDP-43 triggers additional nitrosative stress, representing positive feed forward leading to further SNO-TDP-43 formation and disulfide-linked oligomerization/aggregation. Critically, we show that these redox reactions facilitate cell spreading in vivo and interfere with the TDP-43 RNA-binding activity, affecting SNMT1 and phospho-(p)CREB levels, thus contributing to neuronal damage in ALS/FTD disorders.


Assuntos
Esclerose Lateral Amiotrófica/metabolismo , Proteínas de Ligação a DNA/metabolismo , Demência Frontotemporal/metabolismo , S-Nitrosotióis/metabolismo , Esclerose Lateral Amiotrófica/patologia , Encéfalo/metabolismo , Encéfalo/patologia , Cisteína/metabolismo , Proteínas de Ligação a DNA/química , Demência Frontotemporal/patologia , Humanos , Células-Tronco Pluripotentes Induzidas/metabolismo , Neurônios Motores/metabolismo , Óxido Nítrico/metabolismo , Agregação Patológica de Proteínas , Processamento Pós-Transcricional do RNA , Espécies Reativas de Nitrogênio/metabolismo , S-Nitrosotióis/química , Estresse Fisiológico
2.
Mol Psychiatry ; 26(10): 5751-5765, 2021 10.
Artigo em Inglês | MEDLINE | ID: mdl-32467645

RESUMO

Beginning at early stages, human Alzheimer's disease (AD) brains manifest hyperexcitability, contributing to subsequent extensive synapse loss, which has been linked to cognitive dysfunction. No current therapy for AD is disease-modifying. Part of the problem with AD drug discovery is that transgenic mouse models have been poor predictors of potential human treatment. While it is undoubtedly important to test drugs in these animal models, additional evidence for drug efficacy in a human context might improve our chances of success. Accordingly, in order to test drugs in a human context, we have developed a platform of physiological assays using patch-clamp electrophysiology, calcium imaging, and multielectrode array (MEA) experiments on human (h)iPSC-derived 2D cortical neuronal cultures and 3D cerebral organoids. We compare hiPSCs bearing familial AD mutations vs. their wild-type (WT) isogenic controls in order to characterize the aberrant electrical activity in such a human context. Here, we show that these AD neuronal cultures and organoids manifest increased spontaneous action potentials, slow oscillatory events (~1 Hz), and hypersynchronous network activity. Importantly, the dual-allosteric NMDAR antagonist NitroSynapsin, but not the FDA-approved drug memantine, abrogated this hyperactivity. We propose a novel model of synaptic plasticity in which aberrant neural networks are rebalanced by NitroSynapsin. We propose that hiPSC models may be useful for screening drugs to treat hyperexcitability and related synaptic damage in AD.


Assuntos
Doença de Alzheimer , Células-Tronco Pluripotentes Induzidas , Potenciais de Ação , Doença de Alzheimer/tratamento farmacológico , Doença de Alzheimer/genética , Animais , Modelos Animais de Doenças , Camundongos , Redes Neurais de Computação , Neurônios
3.
J Neurovirol ; 27(3): 367-378, 2021 06.
Artigo em Inglês | MEDLINE | ID: mdl-33876414

RESUMO

In the brain, both HIV-1 and methamphetamine (meth) use result in increases in oxidative and nitrosative stress. This redox stress is thought to contribute to the pathogenesis of HIV-associated neurocognitive disorder (HAND) and further worsening cognitive activity in the setting of drug abuse. One consequence of such redox stress is aberrant protein S-nitrosylation, derived from nitric oxide, which may disrupt normal protein activity. Here, we report an improved, mass spectrometry-based technique to assess S-nitrosylated protein in human postmortem brains using selective enrichment of S-nitrosocysteine residues with an organomercury resin. The data show increasing S-nitrosylation of tricarboxylic acid (TCA) enzymes in the setting of HAND and HAND/meth use compared with HIV+ control brains without CNS pathology. The consequence is systematic inhibition of multiple TCA cycle enzymes, resulting in energy collapse that can contribute to the neuronal and synaptic damage observed in HAND and meth use.


Assuntos
Ciclo do Ácido Cítrico/efeitos dos fármacos , Disfunção Cognitiva/metabolismo , Infecções por HIV/metabolismo , Metanfetamina/efeitos adversos , Processamento de Proteína Pós-Traducional , Transtornos Relacionados ao Uso de Substâncias/metabolismo , Autopsia , Bancos de Espécimes Biológicos , Encéfalo/efeitos dos fármacos , Encéfalo/enzimologia , Encéfalo/patologia , Ciclo do Ácido Cítrico/genética , Disfunção Cognitiva/complicações , Disfunção Cognitiva/patologia , Disfunção Cognitiva/virologia , Cisteína/análogos & derivados , Cisteína/metabolismo , Infecções por HIV/complicações , Infecções por HIV/patologia , Infecções por HIV/virologia , HIV-1/crescimento & desenvolvimento , HIV-1/patogenicidade , Humanos , Masculino , Pessoa de Meia-Idade , Mitocôndrias/efeitos dos fármacos , Mitocôndrias/enzimologia , Mitocôndrias/patologia , Neurônios/efeitos dos fármacos , Neurônios/enzimologia , Neurônios/patologia , Óxido Nítrico/metabolismo , S-Nitrosotióis/metabolismo , Transtornos Relacionados ao Uso de Substâncias/complicações , Transtornos Relacionados ao Uso de Substâncias/patologia , Transtornos Relacionados ao Uso de Substâncias/virologia , Sinapses/efeitos dos fármacos , Sinapses/patologia
5.
Adv Sci (Weinh) ; : e2400545, 2024 May 21.
Artigo em Inglês | MEDLINE | ID: mdl-38773714

RESUMO

Standard single-cell (sc) proteomics of disease states inferred from multicellular organs or organoids cannot currently be related to single-cell physiology. Here, a scPatch-Clamp/Proteomics platform is developed on single neurons generated from hiPSCs bearing an Alzheimer's disease (AD) genetic mutation and compares them to isogenic wild-type controls. This approach provides both current and voltage electrophysiological data plus detailed proteomics information on single-cells. With this new method, the authors are able to observe hyperelectrical activity in the AD hiPSC-neurons, similar to that observed in the human AD brain, and correlate it to ≈1400 proteins detected at the single neuron level. Using linear regression and mediation analyses to explore the relationship between the abundance of individual proteins and the neuron's mutational and electrophysiological status, this approach yields new information on therapeutic targets in excitatory neurons not attainable by traditional methods. This combined patch-proteomics technique creates a new proteogenetic-therapeutic strategy to correlate genotypic alterations to physiology with protein expression in single-cells.

6.
Cell Chem Biol ; 30(8): 965-975.e6, 2023 08 17.
Artigo em Inglês | MEDLINE | ID: mdl-37478858

RESUMO

A causal relationship between mitochondrial metabolic dysfunction and neurodegeneration has been implicated in synucleinopathies, including Parkinson disease (PD) and Lewy body dementia (LBD), but underlying mechanisms are not fully understood. Here, using human induced pluripotent stem cell (hiPSC)-derived neurons with mutation in the gene encoding α-synuclein (αSyn), we report the presence of aberrantly S-nitrosylated proteins, including tricarboxylic acid (TCA) cycle enzymes, resulting in activity inhibition assessed by carbon-labeled metabolic flux experiments. This inhibition principally affects α-ketoglutarate dehydrogenase/succinyl coenzyme-A synthetase, metabolizing α-ketoglutarate to succinate. Notably, human LBD brain manifests a similar pattern of aberrantly S-nitrosylated TCA enzymes, indicating the pathophysiological relevance of these results. Inhibition of mitochondrial energy metabolism in neurons is known to compromise dendritic length and synaptic integrity, eventually leading to neuronal cell death. Our evidence indicates that aberrant S-nitrosylation of TCA cycle enzymes contributes to this bioenergetic failure.


Assuntos
Células-Tronco Pluripotentes Induzidas , Doença de Parkinson , Sinucleinopatias , Humanos , Sinucleinopatias/metabolismo , Células-Tronco Pluripotentes Induzidas/metabolismo , Doença de Parkinson/metabolismo , Neurônios/metabolismo , Encéfalo/metabolismo
7.
Science ; 371(6526)2021 01 15.
Artigo em Inglês | MEDLINE | ID: mdl-33273062

RESUMO

Here we describe mechanistically distinct enzymes (a kinase, a guanosine triphosphatase, and a ubiquitin protein hydrolase) that function in disparate biochemical pathways and can also act in concert to mediate a series of redox reactions. Each enzyme manifests a second, noncanonical function-transnitrosylation-that triggers a pathological biochemical cascade in mouse models and in humans with Alzheimer's disease (AD). The resulting series of transnitrosylation reactions contributes to synapse loss, the major pathological correlate to cognitive decline in AD. We conclude that enzymes with distinct primary reaction mechanisms can form a completely separate network for aberrant transnitrosylation. This network operates in the postreproductive period, so natural selection against such abnormal activity may be decreased.


Assuntos
Doença de Alzheimer/enzimologia , Quinase 5 Dependente de Ciclina/metabolismo , Dinaminas/metabolismo , Óxido Nítrico Sintase/metabolismo , Óxido Nítrico/metabolismo , Sinapses/enzimologia , Doença de Alzheimer/patologia , Peptídeos beta-Amiloides/metabolismo , Animais , Cisteína/genética , Cisteína/metabolismo , Modelos Animais de Doenças , Células HEK293 , Humanos , Camundongos , Camundongos Transgênicos , Mutação , Nitroarginina/farmacologia , Oxirredução , Processamento de Proteína Pós-Traducional/efeitos dos fármacos , Sinapses/patologia , Ubiquitina Tiolesterase/genética , Ubiquitina Tiolesterase/metabolismo
8.
J Immunol Methods ; 341(1-2): 50-8, 2009 Feb 28.
Artigo em Inglês | MEDLINE | ID: mdl-19041653

RESUMO

Analysis of antibody responses to self-antigens has driven the development of the field of tumor immunology, with the identification of many protein targets found in cancer but with limited expression in normal tissues. Protein microarray technologies offer an unprecedented platform to assay the serological response of cancer patients to tumor antigens in a comprehensive fashion, against many proteins simultaneously. We developed an array containing 329 full-length proteins, originally identified as antigenic in various cancer patients by serological expression cloning (SEREX), that were immobilized as folded, functional products accessible for antibody binding. To validate the use of these microarrays, we selected 31 sera from non-small cell lung cancer patients previously known to react to the following antigens by ELISA: LAGE-1/CTAG2, MAGEA4, TP53, SSX and SOX2. These sera were compared with 22 sera from healthy donors for reactivity against a series of antigens present on microarrays. The sensitivity and specificity of the arrays compared favorably with standard ELISA techniques (94% concordance). We present here a stringent strategy for data analysis and normalization that is applicable to protein arrays in general, and describe findings suggesting that this approach is suitable for defining potential antigenic targets for cancer vaccine development, serum antibody signatures with clinical value, characterization of predictive serum markers for experimental therapeutics, and eventually for the serological definition of the cancer proteome (seromics).


Assuntos
Anticorpos Antineoplásicos/sangue , Antígenos de Neoplasias/imunologia , Carcinoma Pulmonar de Células não Pequenas/sangue , Neoplasias Pulmonares/sangue , Análise Serial de Proteínas , Dobramento de Proteína , Anticorpos Antineoplásicos/química , Anticorpos Antineoplásicos/imunologia , Antígenos de Neoplasias/química , Carcinoma Pulmonar de Células não Pequenas/imunologia , Feminino , Humanos , Neoplasias Pulmonares/imunologia , Masculino , Valor Preditivo dos Testes , Conformação Proteica
9.
Am J Ther ; 2(11): 858-863, 1995 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-11854799

RESUMO

Nonsteroidal anti-inflammatory drugs (NSAIDs) have the ability to induce acute deterioration in renal function by inhibiting the production of vasodilatory prostaglandins, thereby disrupting intrarenal hemodynamic balance in patients with stable, mild, chronic renal failure. Misoprostol is a synthetic prostaglandin E-1 analog suitable for oral administration and is widely used in conjunction with NSAIDs to prevent another NSAID-induced complication, gastric ulcers. This investigation utilized a prospective double-blind, randomized, placebo-controlled crossover study designed to evaluate the possible renal protective effects of misoprostol on the renal function of patients with mild, stable, chronic renal failure, who intercurrently ingested ibuprofen 800 mg 8H or indomethacin 25 mg 8H. The mean baseline glomerular filtration rate of the patients who participated in the study was 53 ml/min (misoprostol)/55 ml/min (placebo), and 57 ml/min (misoprostol)/57 ml/min (placebo) in Study I (ibuprofen) and Study II (indomethacin), respectively. At this level of renal functional impairment, the use of the selected NSAIDs did not produce further significant impairment of renal function; hence, a renal protective role for misoprostol could not be demonstrated. To solve the question posed in our study, it will be necessary to conduct future investigations utilizing a recruitment GFR and serum creatinine values in the range of 35 ml/min and less and 2.0 mg/dl and greater, respectively.

10.
Phys Rev Lett ; 88(1): 015506, 2002 Jan 07.
Artigo em Inglês | MEDLINE | ID: mdl-11800965

RESUMO

The bulk modulus of scheelite-structured ZrSiO(4) is 301.4+/-12.5 GPa, as derived from static compression experiments to 52.5 GPa. It is as stiff as the most incompressible known silicate, SiO(2) stishovite. This high incompressibility indicates that octahedrally coordinated silicon is not required to generate ultrastiff silicates: ZrSiO(4) scheelite is the most incompressible material containing SiO(4) tetrahedra. Its incompressibility is in accord with a semitheoretical relation we derive for the bulk modulus of scheelite-structured materials. Based upon correlations between incompressibility and hardness, scheelite-structured oxides may thus represent a new family of ultrahard materials.

11.
Proc Natl Acad Sci U S A ; 101(39): 14023-6, 2004 Sep 28.
Artigo em Inglês | MEDLINE | ID: mdl-15381767

RESUMO

We present in situ observations of hydrocarbon formation via carbonate reduction at upper mantle pressures and temperatures. Methane was formed from FeO, CaCO(3)-calcite, and water at pressures between 5 and 11 GPa and temperatures ranging from 500 degrees C to 1,500 degrees C. The results are shown to be consistent with multiphase thermodynamic calculations based on the statistical mechanics of soft particle mixtures. The study demonstrates the existence of abiogenic pathways for the formation of hydrocarbons in the Earth's interior and suggests that the hydrocarbon budget of the bulk Earth may be larger than conventionally assumed.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA